全文获取类型
收费全文 | 298984篇 |
免费 | 11722篇 |
国内免费 | 8217篇 |
专业分类
耳鼻咽喉 | 2143篇 |
儿科学 | 8130篇 |
妇产科学 | 5302篇 |
基础医学 | 30916篇 |
口腔科学 | 3597篇 |
临床医学 | 28708篇 |
内科学 | 50976篇 |
皮肤病学 | 2102篇 |
神经病学 | 23041篇 |
特种医学 | 13137篇 |
外国民族医学 | 70篇 |
外科学 | 41565篇 |
综合类 | 21261篇 |
现状与发展 | 24篇 |
一般理论 | 5篇 |
预防医学 | 25700篇 |
眼科学 | 6354篇 |
药学 | 22113篇 |
122篇 | |
中国医学 | 6671篇 |
肿瘤学 | 26986篇 |
出版年
2024年 | 358篇 |
2023年 | 1864篇 |
2022年 | 4753篇 |
2021年 | 5983篇 |
2020年 | 4321篇 |
2019年 | 4108篇 |
2018年 | 25659篇 |
2017年 | 20779篇 |
2016年 | 22674篇 |
2015年 | 6134篇 |
2014年 | 7357篇 |
2013年 | 6856篇 |
2012年 | 15742篇 |
2011年 | 30404篇 |
2010年 | 24470篇 |
2009年 | 16123篇 |
2008年 | 25732篇 |
2007年 | 27963篇 |
2006年 | 7024篇 |
2005年 | 8590篇 |
2004年 | 7720篇 |
2003年 | 8457篇 |
2002年 | 5979篇 |
2001年 | 3486篇 |
2000年 | 3716篇 |
1999年 | 3618篇 |
1998年 | 2444篇 |
1997年 | 2372篇 |
1996年 | 1654篇 |
1995年 | 1557篇 |
1994年 | 1358篇 |
1993年 | 880篇 |
1992年 | 1262篇 |
1991年 | 1158篇 |
1990年 | 1051篇 |
1989年 | 896篇 |
1988年 | 762篇 |
1987年 | 706篇 |
1986年 | 529篇 |
1985年 | 491篇 |
1984年 | 267篇 |
1983年 | 198篇 |
1982年 | 142篇 |
1981年 | 116篇 |
1980年 | 115篇 |
1979年 | 122篇 |
1978年 | 67篇 |
1975年 | 60篇 |
1974年 | 84篇 |
1938年 | 61篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
Jae Eun Choi Tyler Werbel Zhenping Wang Chia Chi Wu Tony L. Yaksh Anna Di Nardo 《Journal of dermatological science》2019,93(1):58-64
Background
Rosacea is a chronic inflammatory skin condition whose etiology has been linked to mast cells and the antimicrobial peptide cathelicidin LL-37. Individuals with refractory disease have demonstrated clinical benefit with periodic injections of onabotulinum toxin, but the mechanism of action is unknown.Objectives
To investigate the molecular mechanism by which botulinum toxin improves rosacea lesions.Methods
Primary human and murine mast cells were pretreated with onabotulinum toxin A or B or control. Mast cell degranulation was evaluated by β-hexosaminidase activity. Expression of botulinum toxin receptor Sv2 was measured by qPCR. The presence of SNAP-25 and VAMP2 was established by immunofluorescence. In vivo rosacea model was established by intradermally injecting LL-37 with or without onabotulinum toxin A pretreatment. Mast cell degranulation was assessed in vivo by histologic counts. Rosacea biomarkers were analyzed by qPCR of mouse skin sections.Results
Onabotulinum toxin A and B inhibited compound 48/80-induced degranulation of both human and murine mast cells. Expression of Sv2 was established in mouse mast cells. Onabotulinum toxin A and B increased cleaved SNAP-25 and decreased VAMP2 staining in mast cells respectively. In mice, injection of onabotulinum toxin A significantly reduced LL-37-induced skin erythema, mast cell degranulation, and mRNA expression of rosacea biomarkers.Conclusions
These findings suggest that onabotulinum toxin reduces rosacea-associated skin inflammation by directly inhibiting mast cell degranulation. Periodic applications of onabotulinum toxin may be an effective therapy for refractory rosacea and deserves further study. 相似文献3.
4.
全国名中医天津中医药大学第一附属医院针灸科武连仲教授用多年的临床经验总结概括出针刺的理、法、方、穴、术,其创立的"通经止痛"针刺疗法在临床中疗效佳,武老在治疗坐骨神经痛时,取足太阳膀胱经和足少阳胆经具有走窜针感的经穴为主穴,其配伍精确,组方严密,手法独特,可供临床参考。本文将武老运用"痛经止痛"针刺法治疗坐骨神经痛的经验从"理、法、方、穴、术"方面做浅述。 相似文献
5.
目的:综述运动系统软组织损伤引起慢性疼痛的各种治疗方法的研究进展。资料来源:应用计算机检索Medline1980—01/2006—04与运动系统软组织损伤引起慢性疼痛的治疗相关文章,检索词“Soft tissue injury,pain.chronic,comprehensive therapy”,并限定文章语言种类为“English”;同时计算机检索中国期刊全文数据库1994—01/2006-04期间的相关文章,检索词“软组织损伤、慢性疼痛、治疗方法”,并限定语言种类为中文。同时手工查阅相关书籍。资料选择:对资料进行初审,所选文献内容符合:①软组织损伤引起的慢性疼痛药物治疗的研究。②软组织损伤引起的慢性疼痛微创治疗的研究。③软组织损伤引起的慢性疼痛运动疗法的研究。④软组织损伤引起的慢性疼痛心理治疗的研究。⑤软组织损伤引起的慢性疼痛其他疗法的研究。排除重复性研究的文献。资料提炼:共收集到40篇关于软组织损伤引起的慢性疼痛治疗方法的文献,均为全文,23篇符合纳入标准,排除17篇重复性研究。同时录入书籍3本。资料综合:软组织损伤引起的慢性疼痛的产生是生理、心理及社会因素复杂结合的结果,个体表现差异较大,目前尚无特效治疗方法,常用的治疗方法有:药物治疗、微创治疗、运动疗法、心理治疗、物理疗法及其他疗法。结论:对于软组织损伤引起的慢性疼痛的治疗必须以整体的观点对其进行合理的评估和个体化治疗,才能收到良好的效果。 相似文献
6.
7.
Weiping Ren Bin Wu Xin Peng Jing Hua Hsiao-Nan Hao Paul H Wooley 《Journal of orthopaedic research》2006,24(8):1575-1586
Signaling of RANK (receptor activator of nuclear factor kappa B) through its ligand RANKL appears critical in osteolysis associated with aseptic loosening (AL). The purpose of this study was to investigate the role of RANK in a murine osteolysis model developed in RANK knockout (RANK(-/-)) mice. Ultra high molecular weight polyethylene (UHMWPE) debris was introduced into established air pouches on RANK(-/-) mice, followed by implantation of calvaria bone from syngeneic littermates. Wild type C57BL/6 (RANK(+/+)) mice injected with either UHMWPE or saline alone were included in this study. Pouch tissues were collected 14 days after UHMWPE inoculation for molecular and histology analysis. Results showed that UHMWPE stimulation induced strong pouch tissue inflammation in RANK(-/-) mice, as manifested by inflammatory cellular infiltration, pouch tissue proliferation, and increased gene expression of IL-1beta, TNFalpha, and RANKL. However, the UHMWPE-induced inflammation in RANK(-/-) mice was not associated with the osteoclastic bone resorption observed in RANK(+/+) mice. In RANK(+/+) mice subjected to UHMWPE stimulation, a large number of TRAP(+) cells were found on the implanted bone surface, where active osteoclastic bone resorption was observed. No TRAP(+) cells were found in UHMWPE-containing pouch tissues of RANK(-/-) mice. Consistent with the lack of osteoclastic activity shown by TRAP staining, no significant UHMWPE particle-induced bone resorption was found in RANK(-/-) mice. A well preserved bone collagen content (Van Gieson staining) and normal plateau surface contour [microcomputed tomography (microCT)] of implanted bone was observed in RANK(-/-) mice subjected to UHMWPE stimulation. In conclusion, this study provides the evidence that UHMWPE particles induce strong inflammatory responses, but not associated with osteoclastic bone resorption in RANK(-/-) mice. This indicates that RANK signaling is essential for UHMWPE particle-induced osteoclastic bone resorption, but does not participate in UHMWPE particle-induced inflammatory response. 相似文献
8.
9.
10.